
    
      A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety
      of a CKD-330 versus Amlodipine Monotherapy in Hypertensive Patients Inadequately Controlled
      by Amlodipine Monotherapy
    
  